MRNA Jan 2025 210.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

3.0000

+0.2200

(+7.91%)

As of 09:34AM EDT. Market open.

Loading interactive chart…

Yahoo Finance
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
Investor's Business Daily
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Moderna stock toppled Friday after the FDA delayed an approval decision on its RSV vaccine until the end of the month.
Barrons.com
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
The agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or quality.